D-Wave Quantum: A 19% Sector Surge, Two Cut Price Targets and a Solver That Runs 15 Seconds Flat

D-Wave Quantum shares climbed 19% on Friday, carried higher by a broad advance across the quantum computing sector. Media reports credited IonQ's quarterly results and its raised revenue guidance with providing the tailwind. Yet the rally arrives against a more sober backdrop: two research houses have trimmed their price targets on D-Wave in the space of a week, even as both kept their positive ratings intact. That tension — buoyant sector sentiment on one side, reduced expectations on the other — frames the debate for investors ahead of the company's own third-quarter 2026 results, scheduled for release before the market opens on November 10, with a accompanying webcast set for 8:00 a.m. Eastern Time.

Wedbush and B. Riley Cut, but Stay Bullish

Wedbush lowered its price target on D-Wave Quantum to $30 from $37 on Wednesday, while maintaining its "Outperform" rating. The combination carries a clear message: constructive on the underlying story, more cautious on the upside being priced in. Earlier, on November 2, B. Riley Securities' Craig Ellis had already reduced his target to $27 from $40, with the buy recommendation left unchanged.

Both moves point in the same direction, and the pattern matters. An unchanged positive rating speaks to confidence in the company, provided the expectations behind it are met. A lower target, meanwhile, argues for restraint in valuation. Investors who focus only on the bullish ratings may be underweighting the correction, while those who read the cuts as a verdict on the business are overlooking the fact that neither analyst walked away from the stock.

A Faster Solver as the Operational Test

Technical progress could supply the operational argument that justifies the ratings. On Wednesday, D-Wave announced improvements to its hybrid Stride solver. According to the company, the upgraded version found better solutions in 15 seconds than its predecessor managed in 120 seconds in comparative benchmarking on production line sequencing.

That combination — better results in less computing time — is a tangible data point, and it deserves more weight than general enthusiasm for the quantum sector, provided the advantage holds up under real-world conditions. D-Wave also launched a learning path on applied quantum optimization consisting of three courses, a sensible complement to the product work if it makes practical use of the technology easier to grasp. The link between capability and application is where the investment case lives: the solver offers a concrete technical reference point, while the course addresses how customers actually work with the technology.

A 91.90% Result, With Caveats Attached

A second application field emerged on November 2, when researchers at Florida Atlantic University examined lung cancer prediction on limited data. Their approach using quantum support vector machines reached 91.90% accuracy on D-Wave's quantum hardware.

Such research could draw further interest from potential users, provided follow-up studies confirm the benefit. D-Wave itself labeled the results preliminary and pointed to an expanded dataset, which tempers the economic read-through. A positive assessment of this line of research requires that further investigation support its viability. The same logic applies to optimization work: commercial value depends on how well results transfer to specific customer problems.

The Gap Between Demonstration and Revenue

The central risk, then, is the lag between a convincing demonstration and durable commercial use. If technical advances generate attention while their economic implementation proceeds more slowly than investors expect, the case for caution strengthens. Anyone betting on the application potential must factor in that its economic contribution may only become visible step by step. The thesis would gain credibility once D-Wave can tie technical performance and revenue development more closely together.

Revenue is the decisive yardstick. It gives investors a financial measure of how far D-Wave has turned its technology into something economically usable — and that measure becomes more meaningful if the company can explain the trend through concrete applications and customer activity. A revenue trajectory that, together with management's commentary, points to stronger commercial adoption would support a more favorable view. Progress that trails the interest in the technology's possibilities would argue for prudence.

What November 10 Must Deliver

Until practical advances are matched by a comprehensible business trajectory, a constructive stance is defensible. If that link breaks — technical headlines piling up against weak commercial execution — the foundation for further optimism weakens. On November 10, attention will fall on the results themselves and on commentary regarding customer demand. The question for investors is whether D-Wave can lay out a plausible path from capable applications to commercial business. That is the standard against which the recent burst of optimism must be measured — and the point at which the sector's tailwind either finds support in the company's own numbers or gives way to the caution already visible in two lowered targets.